The GHIT Fund has awarded a grant of ~$4.5m to Fluxus for developing an ultrasensitive point-of-care (POC) urine test for ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Roche has introduced its Chest Pain Triage algorithm, which is designed to rapidly identify acute coronary syndrome (ACS).

BD has received 510(k) clearance from the FDA for the Phasix ST Umbilical Hernia Patch, enabling the launch of the product ...